Very-Low Energy Diet for Preconception Health
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes those who have recently used anti-obesity drugs or appetite suppressants.
What data supports the effectiveness of the treatment Very-low energy Diet (VLED) for preconception health?
Very-low energy diets (VLEDs) have been shown to achieve greater long-term weight loss compared to behavioral programs alone, with studies indicating a weight loss of 1.5-2.5 kg per week. They are effective in reducing liver size and abdominal fat, which can be beneficial before obesity surgery, and may improve glucose metabolism in type 2 diabetes better than conventional diets.12345
Is a very-low energy diet (VLED) generally safe for humans?
Very-low energy diets (VLEDs) can lead to rapid weight loss, which may raise concerns about maternal nutrition and potential risks to early fetal development, such as exposure to ketosis. However, they have been used successfully in managing obesity, diabetes, and hypertension, suggesting they can be safe when monitored properly.678910
How does the Very-low energy Diet (VLED) treatment differ from other treatments for preconception health in women with obesity?
The Very-low energy Diet (VLED) is unique because it offers substantial and rapid weight loss before pregnancy, which is crucial for improving pregnancy outcomes in women with obesity. Unlike lifestyle modifications that result in modest weight loss or bariatric surgery that may pose risks to the offspring, VLED provides a balanced approach by achieving significant weight loss without surgical intervention.67101112
What is the purpose of this trial?
Our hypothesis is that aggressive preconception weight loss in obese women will improve the metabolic health of the mother and the intrauterine environment. An optimized developmental environment will normalize fetal growth and improve clinical fetal and infant outcomes, and theoretically reduce future susceptibility to obesity and cardiometabolic disease.
Research Team
Amy Rothberg, MD, PhD
Principal Investigator
University of Michigan
Eligibility Criteria
This trial is for obese women with a BMI between 30 and 45 who want to lose weight before getting pregnant. They should not have infertility issues, significant medical conditions, or a history of certain treatments like bariatric surgery. Healthy-weight women with a BMI up to 25 can also join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Preconception Weight Loss Intervention
Participants undergo a dietary intervention aimed at preconception weight loss, with a focus on either a very-low energy diet (VLED) or standard of care (SOC) nutrition counseling.
Pregnancy Monitoring
Participants are monitored throughout pregnancy with assessments of fetal growth, maternal metabolite levels, and other health indicators.
Delivery and Immediate Postpartum
Assessment of delivery outcomes, including mode of delivery and immediate neonatal health metrics such as body fat mass and metabolome analysis.
Infant Follow-up
Infant growth and health are monitored at regular intervals to assess long-term outcomes related to the preconception intervention.
Treatment Details
Interventions
- Very-low energy Diet (VLED)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator